The digestive enzymes market has seen considerable growth due to a variety of factors.
• The market size of digestive enzymes has seen a swift surge lately. The market is projected to expand from a value of $1.09 billion in 2024 to $1.2 billion in 2025, showcasing a Compound Annual Growth Rate (CAGR) of 10.7%.
The past growth trends can be connected with factors such as a heightened awareness about digestive health, shifts in dietary habits, an increasing elderly population, the occurrence of gastrointestinal disorders, the growth spurt in the nutraceutical industry, advancements in research and development, and the widening reach of e-commerce.
The digestive enzymes market is expected to maintain its strong growth trajectory in upcoming years.
• In the upcoming years, the digestive enzymes market is anticipated to experience swift expansion. The market is projected to escalate to $1.96 billion in 2029, demonstrating a compound annual growth rate (CAGR) of 13.0%.
This anticipated surge throughout the forecast period is due to factors like health-aware consumers, the incorporation of mainstream healthcare, and the popularity of plant-based and natural products. Other significant trends during this period will be innovative formulas, tailored enzyme formulations, the use of clean and natural components, personalized nutrition and testing, and ongoing research and innovation.
Growth in the digestive enzymes market is being propelled by the escalating incidence of gastrointestinal disorders across various age groups. These disorders, which impact the entire digestive tract—from the mouth, oesophagus, stomach, to the small and large intestines and the anus—are a result of an insufficient count of digestive enzymes. For effective treatment, digestive enzymes have to be ingested either as a dietary supplement or medication. The rising cases of gastrointestinal disorders can be attributed to a variety of factors, including smoking, diet and genetics, sanitation, increased utilization of antibiotics, and environmental shifts stemming from industrialization and urbanization. A survey by the American Gastroenterological Association, a US-based body, released in September 2022, reveals that 60-70 million Americans are struggling with gastrointestinal (GI) conditions, which can seriously hinder day-to-day activities. The data further points out that nearly 40% of Americans put a halt on everyday activities last year due to uneasy bowel symptoms. FGID was observed to be more prevalent in women compared to men. Moreover, a comprehensive multinational research disclosed that over 40% of the global population suffers from FGIDs. Hence, the surge in digestive diseases is instrumental in the expansion of the digestive enzymes market.
The digestive enzymes market covered in this report is segmented –
1) By Enzyme Type: Carbohydrates, Protease, Lipase, Other Enzyme Types
2) By Origin: Animal, Fungi, Microbial, Plant
3) By Application: Indigestion, Chronic Pancreatitis, Irritable Bowel Syndrome, Other Applications
4) By Distribution Channel: Retail Stores, Online Stores
Subsegments:
1) By Carbohydrates: Amylase, Alpha-Galactosidase, Lactase, Sucrase, Maltase
2) By Protease: Pepsin, Trypsin, Chymotrypsin, Bromelain, Papain
3) By Lipase: Pancreatic Lipase, Gastric Lipase, Lingual Lipase
4) By Other Enzyme Types: Cellulase, Lactase, Phytase, Beta-Glucanase, Xylanase
Businesses within the digestive enzymes market are directing resources towards creating tailored digestive enzymes. These customized enzymes, designed to aid those with digestion sensitivities, may also possess multiple enzymes within one product. The process of manufacturing digestive enzymes has seen an evolution towards creating custom enzymes to make the digestion of varied food types easier. For instance, DigeZyme, a product of Sabinsa, an American company specializing in herbal extracts, cosmeceuticals, minerals, and dietary supplements, is a multi-enzyme compound. It contains five distinct enzymes - cellulase, lactase, amylase, lipase, and protease. It's specifically designed for those struggling with the digestion of carbohydrates, fats, and proteins. Continued investment in the development of these personalized digestive enzymes appears to be an ongoing trend among these companies.
Major companies operating in the digestive enzymes market include:
• Garden of Life LLC
• Biotics Research Corporation
• Klaire Laboratories
• Abbott Nutrition
• AbbVie Inc.
• Johnson & Johnson Inc.
• Amway Corporation
• Food State Inc.
• Matsun Nutrition
• Metagenics Inc.
• Twinlab Corporation
• AST Enzymes
• Vemo Corp.
• Advanced Vital Enzymes Pvt. Ltd.
• Zeus Biotech Limited
• Vox Nutrition Inc.
• Enzyme Bioscience Pvt. Ltd.
• XYMOGEN Inc.
• Douglas Laboratories
• Thorne Research Inc.
• Integrative Therapeutics LLC
• Pure Encapsulations Inc.
• Ortho Molecular Products Inc.
• Designs for Health Inc.
• Master Supplements Inc.
• Proteozymes Pvt Ltd.
• Chr. Hansen Holding A/S
• Danone S.A.
• DSM Nutritional Products AG
• DuPont de Nemours Inc.
• Kerry Group plc
• Koninklijke DSM N.V.
• Lonza Group AG
• Nestle S.A.
• Pfizer Inc.
• Sanofi S.A.
• Specialty Enzymes & Biotechnologies Co.
• Thermo Fisher Scientific Inc.
• Wacker Chemie AG
North America was the largest region in the digestive enzymes market in 2023. Middle East is expected to be the largest growing region in the digestive enzymes market report during the forecast period. The regions covered in the digestive enzymes market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa